William Mack & Associates’s Compass Pathways CMPS Stock Holding History

William Mack & Associates’s Portfolio CMPS Stock Details CMPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$374	Buy	+30	New	+$399	﹤0.01%	818

Other funds holding CMPS

BIT Capital Berlin, Germany $2.89B AUM 111.72% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Eagle Health Investments Greenwich, Connecticut $609M AUM 85.36% 1-Year Est. Return

NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return

Aisling Capital Management New York $299M AUM 39.78% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Creek Drive Management Group San Francisco, California $368M AUM 23.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

William Mack & Associates's CMPS Position: Q3 2026 in Review

William Mack & Associates opened a new position in Compass Pathways (CMPS) in Q3 2026: 30 shares worth $374. The stake represents ﹤0.01% of the portfolio and ranks #818 among its holdings.

182 funds tracked by Wall St. Rank hold CMPS as of Q3 2026.

William Mack & Associates held 30 shares of Compass Pathways worth $374 as of Q3 2026.
Compass Pathways was a new William Mack & Associates position in Q3 2026.
Compass Pathways made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #818 holding.
182 funds tracked by Wall St. Rank held Compass Pathways as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.